{
    "data": [
        {
            "id": "690386b2ecb8a70001459871",
            "title": "Pfizer Blasts Novo Nordisk&#39;s $9 Billion Counteroffer For Metsera As &#39;Reckless&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">On Thursday, <strong>Metsera Inc</strong>. (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MTSR\" target=\"_blank\">MTSR</a>) received an <a href=\"https://www.benzinga.com/topic/mergers-and-acquisitions\" target=\"_blank\">unsolicited acquisition proposal </a>from <strong>Novo Nordisk A/S</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVO\" target=\"_blank\">NVO</a>).</p><!--/$--><!--$--><p class=\"block core-block\">Metsera said the proposal constitutes a “Superior Company Proposal” as defined in Metsera’s existing Merger Agreement with <strong>Pfizer Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PFE\" target=\"_blank\">PFE</a>).</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">In September, Pfizer agreed to acquire Metsera for $47.50 per share in cash, representing an enterprise value of <a href=\"https://www.benzinga.com/m-a/25/09/47787042/pfizer-tries-to-revitalize-obesity-portfolio-with-5-billion-matsera-deal\" rel=\"noreferrer noopener\" target=\"_blank\">approximately $4.9 billion</a>.</p><!--/$--><!--$--><p class=\"block core-block\">The acquisition brings a portfolio of differentiated oral and injectable incretin, non-incretin, and combination therapy candidates.</p><!--/$--><!--$--><p class=\"block core-block\">Novo Nordisk’s proposal is structured in two steps.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>In the first step, immediately following the signing of a definitive agreement, Novo Nordisk would pay <a href=\"https://www.benzinga.com/pressreleases/25/10/n48522694/metsera-receives-unsolicited-proposal-from-novo-nordisk\" rel=\"noreferrer noopener\" target=\"_blank\">Metsera $56.50 per share</a> in cash, as well as certain amounts related to Metsera employee equity and transaction expenses.</li>\n<li>In exchange, Metsera would issue Novo Nordisk non-voting preferred stock representing 50% of Metsera’s share capital.</li>\n<li>On the same day, Metsera would declare a dividend of $56.50 per Metsera common share, payable in cash, to be distributed 10 days later.</li>\n</ul><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">In the second step, which would happen only after receiving approval from Metsera shareholders and relevant regulators, Metsera shareholders would receive a contingent value right representing up to $21.25 per share in cash based on development and regulatory approval milestones.</p><!--/$--><!--$--><p class=\"block core-block\">This proposal values Metsera at up to $77.75 per share, for approximately $9 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Pfizer, in a press release on Thursday, stated that it is aware of Novo Nordisk’s proposal, which it considers<a href=\"https://www.benzinga.com/pressreleases/25/10/b48522228/pfizer-addresses-proposal-for-metsera\" target=\"_blank\"> “reckless and unprecedented.”</a></p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Pfizer stated that it is an attempt by a company with a dominant market position to suppress competition in violation of the law by acquiring an emerging American challenger.</p><!--/$--><!--$--><p class=\"block core-block\">It is also structured in a way that circumvents antitrust laws and carries substantial regulatory and operational risks.</p><!--/$--><!--$--><p class=\"block core-block\">The proposal is illusory and cannot qualify as a superior proposal under Pfizer’s agreement with Metsera.</p><!--/$--><!--$--><p class=\"block core-block\">Pfizer is prepared to pursue all legal avenues to enforce its rights under the agreement.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">As disclosed in Metsera’s proxy, the Board of Metsera previously rejected Novo Nordisk’s proposal due to “a variety of risks” in its deal structure. The Board chose Pfizer over other bidders because none “could complete an acquisition of 100% of Metsera’s equity with the same level of certainty or on the same expected timeline as Pfizer.”</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action</strong>: MTSR stock is up 21.03% at $63.19, and NVO stock is down 2.31% at $50.19 at the last check on Thursday.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/markets/earnings/25/10/48519623/alphabets-ai-bet-delivers-record-100-billion-quarter-cloud-backlog-surges-to-155-billion\" rel=\"noreferrer noopener\" target=\"_blank\">Alphabet’s AI Bet Delivers Record $100 Billion Quarter, Cloud Backlog Surges To $155 Billion</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: jittawit21/Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48533502\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Genetic-Research-And-Biotech-Science-Con.jpeg",
            "link": "https://www.benzinga.com/m-a/25/10/48533502/pfizer-blasts-novo-nordisks-9-billion-counteroffer-for-metsera-as-reckless",
            "pub_date": "2025-10-30 23:39:34",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69038822ecb8a700014599bd",
            "title": "Here&#39;s How Much You Would Have Made Owning Howmet Aerospace Stock In The Last 5 Years",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Howmet Aerospace (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/HWM\" target=\"_blank\">HWM</a>) has outperformed the market over the past 5 years by 47.18% on an annualized basis producing an average annual return of 62.49%. Currently, Howmet Aerospace has a market capitalization of $85.18 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $1000 In HWM:</strong> If an investor had bought $1000 of HWM stock 5 years ago, it would be worth <strong>$11,820.73</strong> today based on a price of $211.00 for HWM at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">Howmet Aerospace's Performance Over Last 5 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761839139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761839139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761839139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-jWAYhW dvGDGG\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48533825/heres-how-much-you-would-have-made-owning-howmet-aerospace-stock-in-the-last-5-years",
            "pub_date": "2025-10-30 23:45:42",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903978eecb8a7000145a39d",
            "title": "A Must See Chart for Those in the AI Trade; Trump Xi Meeting &#39;Amazing&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><!--/$--><!--$--><h4 class=\"wp-block-heading\"><strong>AI Trade Inflection Point</strong></h4><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Please click here for an enlarged chart of <strong>Meta Platforms Inc</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/META\" target=\"_blank\">META</a>).</p><!--/$--><!--$--><p class=\"block core-block\">Note the following:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>This article is about the big picture, not an individual stock.  The chart of META stock is being used to illustrate the point.</li>\n<li>The chart shows the drop in META stock on earnings.</li>\n<li>Our proprietary VUD indicator is the most sensitive measure of net supply and demand in real-time. The orange represents net supply and the green represents net demand. The chart shows the VUD indicator is orange, indicating net supply.</li>\n<li>Here are the key points from Meta's earnings:\n<ul class=\"wp-block-list\">\n<li>Earnings ex-charge came at $7.25 vs. $6.72 consensus.</li>\n<li>Revenue came at $51.2B vs. $49.5B consensus.</li>\n<li>Operating margin came at 40% vs. 43% last year.</li>\n<li>R&amp;D expenses rose 28% on hiring for an AI research unit.</li>\n<li>Meta raised guidance on AI spending for the third time in 2025.</li>\n<li>In a financing deal with an alternative investment manager, Meta moved the debt for its Hyperion data center off of its balance sheet as well as the capex off the cash flow statement. Investors should note that unlike <strong>Amazon.com, Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AMZN\" target=\"_blank\">AMZN</a>), <strong>Alphabet Inc Class C</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GOOG\" target=\"_blank\">GOOG</a>), and <strong>Microsoft Corp </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MSFT\" target=\"_blank\">MSFT</a>), Meta's data centers are not directly revenue generating; Meta's data centers are for its own use.</li>\n<li>Meta plans to offer more AI to its users through its apps.</li>\n</ul>\n</li>\n<li><strong>All of the foregoing is excellent.  Why did META stock drop?  In our analysis,  META stock dropped because the company said capital expenditure growth will be notably higher in FY2026.  To date, the trend has been the higher capital spend on AI, the higher the stock.  META stock shows the trend has changed.  When a trend changes, investors need to pay attention.   </strong></li>\n<li>President Trump called his meeting with China's President Xi ‘amazing.'  President Trump has cut tariffs on China.  So far, details are absent.  The lack of details is bringing in skepticism in a stock market that is priced for perfection.</li>\n<li>Yesterday's chart in the Morning Capsule showed a move up in Nvidia stock on President Trump saying he would discuss Blackwell with President Xi.  For the sake of full transparency, the chart is unchanged from yesterday.</li>\n<li>It turns out that President Trump discussed Nvidia products with President Xi, but not Blackwell.</li>\n<li>Investors should carefully watch how <strong>NVIDIA Corp</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVDA\" target=\"_blank\">NVDA</a>) performs as the day progresses.</li>\n<li>Mag7 earnings continue today with Amazon (AMZN) and <strong>Apple Inc </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AAPL\" target=\"_blank\">AAPL</a>) reporting after the close.</li>\n<li><strong>Momo gurus have been wrong about what Fed Chair Powell could say.  Momo gurus being wrong is nothing new.  Momo gurus have become experts at coming up with new narratives to persuade the momo crowd to buy stocks.  What is unusual is that so far, momo gurus have not come up with a new narrative after Fed Chair Powell's press conference yesterday.  This is bringing selling into the stock market in the early trade as the momo crowd needs a constant impetus to continue buying stocks.   </strong></li>\n</ul><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><h4 class=\"wp-block-heading\"><strong>Magnificent Seven Money Flows</strong></h4><!--/$--><!--$--><p class=\"block core-block\">Most portfolios are now heavily concentrated in the Mag 7 stocks.  To get an edge, investors need to pay attention to early money flows in the Mag 7 stocks on a daily basis.  </p><!--/$--><!--$--><p class=\"block core-block\">In the early trade, money flows are positive in Apple (AAPL) and Alphabet (GOOG).</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">In the early trade, money flows are negative in Amazon (AMZN), Meta (META), NVIDIA Corp (NVDA), Microsoft (MSFT), and <strong>Tesla Inc</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TSLA\" target=\"_blank\">TSLA</a>).</p><!--/$--><!--$--><p class=\"block core-block\">In the early trade, money flows are negative in <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/SPY\" target=\"_blank\">SPY</a>) and <strong>Invesco QQQ Trust Series 1</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/QQQ\" target=\"_blank\">QQQ</a>).</p><!--/$--><!--$--><h4 class=\"wp-block-heading\"><strong>Momo Crowd And Smart Money In Stocks</strong></h4><!--/$--><!--$--><p class=\"block core-block\">Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is <strong>SPDR Gold Trust</strong> (GLD).  The most popular ETF for silver is <strong>iShares Silver Trust </strong>(SLV).  The most popular ETF for oil is <strong>United States Oil ETF</strong> (USO).</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h4 class=\"wp-block-heading\"><strong>Bitcoin</strong></h4><!--/$--><!--$--><p class=\"block core-block\"><strong>Bitcoin</strong> (CRYPTO: <a class=\"ticker\" href=\"https://www.benzinga.com/quote/btc/usd\" target=\"_blank\">BTC</a>) is seeing selling.</p><!--/$--><!--$--><h4 class=\"wp-block-heading\"><strong>What To Do Now</strong></h4><!--/$--><!--$--><p class=\"block core-block\">Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">You can determine your protection bands by adding cash to hedges.  The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.  If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.</p><!--/$--><!--$--><p class=\"block core-block\">A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.  A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.  </strong>When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.  High beta stocks are the ones that move more than the market.</p><!--/$--><!--$--><h4 class=\"wp-block-heading\"><strong>Traditional 60/40 Portfolio</strong></h4><!--/$--><!--$--><p class=\"block core-block\">Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.</p><!--/$--><!--$--><p class=\"block core-block\">Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.  Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever </strong><a href=\"https://thearorareport.com/generate-wealth-newsletter-benzinga\" rel=\"nofollow\" target=\"_blank\"><strong>Generate Wealth Newsletter</strong></a><strong>.</strong></p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.</em></strong></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48536321\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/Opinion/25/10/48536321/a-must-see-chart-for-those-in-the-ai-trade-trump-xi-meeting-amazing",
            "pub_date": "2025-10-31 00:51:23",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690397e0ecb8a7000145a3d7",
            "title": "Coinbase Shares Slide Ahead Of Q3 Earnings: What&#39;s Going On?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Shares of <strong>Coinbase Global Inc</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/COIN\" target=\"_blank\">COIN</a>) are trading lower Thursday afternoon as investors position themselves ahead of the company’s third-quarter earnings release, scheduled for after the market close. Here’s what investors <a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48502190/coinbase-q3-preview-product-diversification-acquisitions-create-a-compelling-opportunity\" target=\"_blank\">need to know</a>.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><em>COIN is encountering selling pressure. <a href=\"https://www.benzinga.com/quote/COIN\" rel=\"noreferrer noopener\" target=\"_blank\">Get the market research here.</a></em></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>What To Know:</strong> Wall Street is anticipating a strong report, with consensus estimates pointing to earnings per share of $1.09 on revenue of $1.78 billion. This would mark a <a href=\"https://www.benzinga.com/quote/COIN/earnings\" target=\"_blank\">significant increase</a> from the same period last year, driven by higher crypto trading volumes during the quarter.</p><!--/$--><!--$--><p class=\"block core-block\">Beyond the headline numbers, investors will be scrutinizing the company’s efforts to diversify its revenue streams. Key areas of focus include growth in staking, derivatives and the company’s layer-2 solution, Base.</p><!--/$--><!--$--><p class=\"block core-block\">The earnings come amid a backdrop of positive developments for the exchange. Earlier this week, Coinbase <a href=\"https://www.benzinga.com/pressreleases/25/10/b48438663/citi-and-coinbase-join-forces-to-boost-digital-asset-payment-capabilities-for-global-clients\" target=\"_blank\">announced</a> a major partnership with Citi to streamline digital asset payments for institutional clients. </p><!--/$--><!--$--><p class=\"block core-block\">Furthermore, CEO <strong>Brian Armstrong</strong> recently stated he is “<a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48398996/coinbase-ceo-brian-armstrong-bullish-on-getting-key-crypto-legislation-passed-by-year-end-were-90-there\" target=\"_blank\">bullish</a>” on the prospects of key crypto legislation passing in the U.S. by the end of the year, a move that would provide much-needed regulatory clarity.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Benzinga Edge Rankings:</strong> Despite the day’s dip, <a href=\"http://benzinga.grsm.io/register174\" target=\"_blank\">Benzinga Edge</a> rankings show the stock holds exceptionally high scores for both Growth (93.95) and Momentum (89.24).</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><strong>COIN Price Action:</strong> Coinbase Global shares were down 2.69% at $339.22 at the time of publication on Thursday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Read Also: <a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48504374/michael-saylor-targets-150000-for-bitcoin-as-strategy-breaks-new-ground-with-sp-rating\" target=\"_blank\">Michael Saylor Targets $150,000 For Bitcoin As Strategy Breaks New Ground With S&amp;P Rating</a></strong></p><!--/$--><!--$--><div class=\"sc-gQfuga iaHpuj\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">How To Buy COIN Stock</h2><!--/$--><!--$--><p class=\"block core-block\">By now you're likely curious about how to participate in the market for Coinbase – be it to purchase shares, or even attempt to bet against the company.</p><!--/$--><!--$--><p class=\"block core-block\">Buying shares is typically done through a brokerage account. You can find a list of <a href=\"https://www.benzinga.com/money/best-stock-trading-platforms\" target=\"_blank\">possible trading platforms here.</a> Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a <a href=\"https://www.benzinga.com/money/how-to-short-a-stock\" target=\"_blank\">stock can be found at this resource.</a>  Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48536363\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Coinbase-Shutterstock_0.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/10/48536363/coinbase-shares-slide-ahead-of-q3-earnings-whats-going-on",
            "pub_date": "2025-10-31 00:52:51",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903962decb8a7000145a290",
            "title": "Here&#39;s How Much You Would Have Made Owning Corning Stock In The Last 5 Years",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Corning (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GLW\" target=\"_blank\">GLW</a>) has outperformed the market over the past 5 years by 6.56% on an annualized basis producing an average annual return of 21.85%. Currently, Corning has a market capitalization of $71.87 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $1000 In GLW:</strong> If an investor had bought $1000 of GLW stock 5 years ago, it would be worth <strong>$2,785.65</strong> today based on a price of $88.95 for GLW at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">Corning's Performance Over Last 5 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761842733_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761842733_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761842733_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48536036/heres-how-much-you-would-have-made-owning-corning-stock-in-the-last-5-years",
            "pub_date": "2025-10-31 00:45:37",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}